相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Hussin A. Rothan et al.
JOURNAL OF AUTOIMMUNITY (2020)
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
J. -M. Michot et al.
ANNALS OF ONCOLOGY (2020)
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
Chi Zhang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Convalescent plasma for patients with COVID-19
Furong Zeng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Reply: Potential role of Janus kinase inhibitors in COVID-19
Maddalena Napolitano et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
Jin Liu et al.
EBIOMEDICINE (2020)
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
Dennis McGonagle et al.
AUTOIMMUNITY REVIEWS (2020)
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review
W. Joost Wiersinga et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
Bingwen Liu et al.
JOURNAL OF AUTOIMMUNITY (2020)
Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator?
Jenifer Gomez-Pastora et al.
CLINICA CHIMICA ACTA (2020)
The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China
Jianhon Fu et al.
THROMBOSIS RESEARCH (2020)
Are Serum Interleukin 6 and Surfactant Protein D Levels Associated with the Clinical Course of COVID-19?
Bugra Kerget et al.
LUNG (2020)
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study (vol 5, pg 33, 2020)
Li Tan et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Mesenchymal Stem Cell Therapy for COVID-19: Present or Future
Ali Golchin et al.
STEM CELL REVIEWS AND REPORTS (2020)
Interobserver Reliability of the Berlin ARDS Definition and Strategies to Improve the Reliability of ARDS Diagnosis
Michael W. Sjoding et al.
CHEST (2018)
Association of the Interleukin-6 rs1800795 Polymorphism with Type 2 Diabetes Mellitus in the Population of the Island of Crete, Greece
Marina N. Plataki et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2018)
Interleukin-6-174G > C (rs1800795) polymorphism distribution and its association with rheumatoid arthritis: A case-control study and meta-analysis
Sajad Ahmad Dar et al.
AUTOIMMUNITY (2017)
Genetic association of pro-inflammatory cytokine gene polymorphisms with coronary artery disease (CAD) in a North Indian population
Sarabjit Mastana et al.
GENE (2017)
The IL6 Gene Promoter SNP and Plasma IL-6 in Response to Diet Intervention
Brinda K. Rana et al.
NUTRIENTS (2017)
IL-6 rs1800795 polymorphism is associated with septic shock-related death in patients who underwent major surgery: a preliminary retrospective study
Maria Angeles Jimenez-Sousa et al.
ANNALS OF INTENSIVE CARE (2017)
Interleukin 6 SNP rs1800797 associates with the risk of adult-onset asthma
T. K. Lajunen et al.
GENES AND IMMUNITY (2016)